EXETER, England, Nov. 10 /CNW/ - Mobious Genomics Ltd, the UK based
bionanotechnology company is pleased to announce that it has received formal
notice of grant from the United States Patent Office for a broad technology
defining patent (US 6908736) covering real-time polynucleotide sequencing.
This patent outlines the use of modified polymerases to achieve direct
molecular sensing of DNA base identity for real-time polynucleotide
sequencing, without the use of engineered nucleotide triphosphates.
This patent was originally allowed by the US patent office during 2004,
but then withdrawn for administrative reasons. The patent has been
subsequently re-examined and re-allowed and has now proceeded to grant.
The patent outlines, inter alia, the realisation of Mobious proprietary
real-time approach in the fluorescent mode.
